IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; IRBESARTAN) — FDA Approval ANDA203630 (AUROBINDO PHARMA LTD)
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE; IRBESARTAN) — FDA Approval ANDA203630 (AUROBINDO PHARMA LTD) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: IRBESARTAN AND HYDROCHLOROTHIAZIDE; Active ingredients: HYDROCHLOROTHIAZIDE; IRBESARTAN; Application number: ANDA20
| Brand name | IRBESARTAN AND HYDROCHLOROTHIAZIDE |
|---|---|
| Active ingredients | HYDROCHLOROTHIAZIDE; IRBESARTAN |
| Application number | ANDA203630 |
| Sponsor | AUROBINDO PHARMA LTD |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 3 |
| First approval date | 20130222 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →